Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

David R. Matthews, J P Hosker, A. Rudenski et al. · Diabetologia · 1985 · 31.4K citations · Full text

Medicine, Endocrinology, Physiology +17

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6.1K citations

Medicine, Internal Medicine, Pharmacotherapy +17

Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C

Stephanos J. Hadziyannis · Annals of Internal Medicine · 2004 · 2.8K citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3

Alessandra Mangia, Rosanna Santoro, Nicola Minerva et al. · New England Journal of Medicine · 2005 · 839 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17